ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31

Could an HPV test with extended genotyping that can individually identify HPV 16, 18, 31, and other genotypes change the way we manage cervical cancer screening results?

In this video, Dr. Mark Stoler, Professor of Pathology and Clinical Gynecology at the University of Virginia Health System, discusses the special case of HPV 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD Onclarity HPV Assay
Cervical Cancer | News & Updates
Press Release: BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test
BD released findings from a survey conducted by The Harris Poll that indicate a significant gap in women’s knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.
Cervical Cancer | News & Updates
Press Release: New Harris Poll Reveals Significant Gaps in Women's Knowledge About Cervical Cancer
Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD
Cervical Cancer | News & Updates
NJBIZ Conversations: Chris Beddard